(4aS,4bR,10aR,10bS,12aS)-7-hydroxy-10a,12a-dimethyl-4,4a,5,6,10,10a,10b,11,12,12a-decahydro-1H-naphtho[2,1-f]isochromene-3,8(4bH,9H)-dione

ID: ALA3751876

Chembl Id: CHEMBL3751876

PubChem CID: 24865937

Max Phase: Preclinical

Molecular Formula: C19H26O4

Molecular Weight: 318.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CC(=O)OC2

Standard InChI:  InChI=1S/C19H26O4/c1-18-7-5-12-11(14(18)9-16(21)23-10-18)3-4-13-17(22)15(20)6-8-19(12,13)2/h11-12,14,22H,3-10H2,1-2H3/t11-,12+,14+,18-,19-/m1/s1

Standard InChI Key:  XRMAJOGFEAYBBA-NQJHRMQHSA-N

Associated Targets(non-human)

Cyp19a1 Cytochrome P450 19A1 (290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 318.41Molecular Weight (Monoisotopic): 318.1831AlogP: 3.56#Rotatable Bonds:
Polar Surface Area: 63.60Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.11CX Basic pKa: CX LogP: 2.60CX LogD: 2.60
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.69Np Likeness Score: 2.62

References

1. Yadav MR, Barmade MA, Tamboli RS, Murumkar PR..  (2015)  Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.,  105  [PMID:26469743] [10.1016/j.ejmech.2015.09.038]

Source